Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | ITCI | BPMC | ||
| Company | Ascendis Pharma ADR | Intra-Cellular Ther | Blueprint Medicines Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 137.25 | 75.24 | 114.50 | ||
| High | 137.25 | 76.10 | 116.00 | ||
| Low | 132.59 | 74.48 | 112.22 | ||
| Last | 135.21 | 74.86 | 114.97 | ||
| Change | -1.31 | -0.08 | +1.51 | ||
| % Change | -0.96% | -0.11% | +1.33% | ||
| Volume | 447,800 | 685,200 | 526,400 | ||
| 20-Day Average Volume | 300,785 | 1,648,805 | 694,265 | ||
| Previous Close | 136.52 | 74.94 | 113.46 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 135.49 | 73.66 | 112.16 | ||
| 20-Day Raw Stochastic | 66.43% | 63.14% | 65.56% | ||
| 20-Day Relative Strength | 50.52% | 55.66% | 58.14% | ||
| Weighted Alpha | +42.65 | +25.05 | +108.75 | ||
| Today's Opinion | 8% Buy | 100% Buy | 96% Buy | ||
| Previous Opinion | 24% Buy | 100% Buy | 96% Buy | ||
| Last Month's Opinion | 24% Sell | 64% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.08% since 07/12/24 | -4.19% since 07/12/24 | -2.39% since 07/12/24 | ||
| Low | 132.59 on 07/19/24 | 74.45 on 07/18/24 | 109.50 on 07/18/24 | ||
| High | 142.21 on 07/16/24 | 79.88 on 07/16/24 | 121.90 on 07/16/24 | ||
| 1-Month | |||||
| %Chg | +9.76% since 06/18/24 | -0.82% since 06/18/24 | +7.74% since 06/18/24 | ||
| Low | 121.07 on 06/20/24 | 66.26 on 07/01/24 | 101.78 on 06/24/24 | ||
| High | 142.21 on 07/16/24 | 79.88 on 07/16/24 | 121.90 on 07/16/24 | ||
| 3-Month | |||||
| %Chg | -3.54% since 04/19/24 | +3.44% since 04/19/24 | +32.38% since 04/19/24 | ||
| Low | 116.63 on 05/14/24 | 64.09 on 05/20/24 | 86.51 on 04/22/24 | ||
| High | 147.45 on 04/23/24 | 79.88 on 07/16/24 | 121.90 on 07/16/24 | ||
| 6-Month | |||||
| %Chg | +2.42% since 01/19/24 | +14.38% since 01/19/24 | +41.85% since 01/19/24 | ||
| Low | 116.63 on 05/14/24 | 62.78 on 02/22/24 | 72.24 on 02/14/24 | ||
| High | 161.00 on 02/26/24 | 84.89 on 04/16/24 | 121.90 on 07/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,873,413 | 7,903,344 | 7,199,077 | ||
| Shares Outstanding, K | 58,231 | 105,575 | 62,617 | ||
| Annual Sales | 288,670,000 | 464,370,000 | 249,380,000 | ||
| Annual Net Income | -521,070,000 | -139,670,000 | -506,980,000 | ||
| Last Quarter Sales | 104,110,000 | 144,870,000 | 96,120,000 | ||
| Last Quarter Net Income | -142,260,000 | -15,250,000 | 89,140,000 | ||
| 60-Month Beta | 0.63 | 1.01 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 05/02/24 | -0.16 on 05/07/24 | -1.32 on 05/02/24 | ||
| Latest Earnings Date | 09/03/24 | 08/01/24 | 08/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||